News From the OHF
Metabolic Support UK (MSUK) has shared the exciting news that Lumasiran (Oxlumo) has been approved in the UK for those living with PH1. We are grateful to the patients, families, and experts in the field that came together and shared their perspectives on PH!
“We would also like to extend our gratitude to the wonderful team at the [OHF] for their support and assistance in the engagement and insight work required for this appraisal.” —MSUK
International Workshop!
